Cargando…

Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway

Discs Large Homolog 5 (DLG5) plays an important role in the maintenance of epithelial cell polarity. Recent research showed that DLG5 is decreased in Yes-associated protein (YAP)-overexpressing cells. However, the exact relationship between DLG5 and YAP is not clear. In this study, we showed that lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Li, Juan, Li, Pingping, Wang, Yaochun, Liang, Zheyong, Jiang, Yina, Li, Jing, Feng, Chen, Wang, Ruiqi, Chen, He, Zhou, Can, Zhang, Jianmin, Yang, Jin, Liu, Peijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294562/
https://www.ncbi.nlm.nih.gov/pubmed/28169360
http://dx.doi.org/10.1038/srep42125
_version_ 1782505264187965440
author Liu, Jie
Li, Juan
Li, Pingping
Wang, Yaochun
Liang, Zheyong
Jiang, Yina
Li, Jing
Feng, Chen
Wang, Ruiqi
Chen, He
Zhou, Can
Zhang, Jianmin
Yang, Jin
Liu, Peijun
author_facet Liu, Jie
Li, Juan
Li, Pingping
Wang, Yaochun
Liang, Zheyong
Jiang, Yina
Li, Jing
Feng, Chen
Wang, Ruiqi
Chen, He
Zhou, Can
Zhang, Jianmin
Yang, Jin
Liu, Peijun
author_sort Liu, Jie
collection PubMed
description Discs Large Homolog 5 (DLG5) plays an important role in the maintenance of epithelial cell polarity. Recent research showed that DLG5 is decreased in Yes-associated protein (YAP)-overexpressing cells. However, the exact relationship between DLG5 and YAP is not clear. In this study, we showed that loss of DLG5 promoted breast cancer cell proliferation by inhibiting the Hippo signaling pathway and increasing nuclear YAP expression. Furthermore, depletion of DLG5 induced epithelial-mesenchymal transition (EMT) and disrupted epithelial cell polarity, which was associated with altered expression of Scribble, ZO1, E-cadherin and N-cadherin and their mislocalization. Interestingly, we first reported that loss of DLG5 inhibited the interaction of Mst1 and Lats1 with Scribble, which was crucial for YAP activation and the transcription of TEA domain (TEAD) family members. In summary, loss of DLG5 expression promoted breast cancer malignancy by inactivating the Hippo signaling pathway and increasing nuclear YAP.
format Online
Article
Text
id pubmed-5294562
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52945622017-02-10 Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway Liu, Jie Li, Juan Li, Pingping Wang, Yaochun Liang, Zheyong Jiang, Yina Li, Jing Feng, Chen Wang, Ruiqi Chen, He Zhou, Can Zhang, Jianmin Yang, Jin Liu, Peijun Sci Rep Article Discs Large Homolog 5 (DLG5) plays an important role in the maintenance of epithelial cell polarity. Recent research showed that DLG5 is decreased in Yes-associated protein (YAP)-overexpressing cells. However, the exact relationship between DLG5 and YAP is not clear. In this study, we showed that loss of DLG5 promoted breast cancer cell proliferation by inhibiting the Hippo signaling pathway and increasing nuclear YAP expression. Furthermore, depletion of DLG5 induced epithelial-mesenchymal transition (EMT) and disrupted epithelial cell polarity, which was associated with altered expression of Scribble, ZO1, E-cadherin and N-cadherin and their mislocalization. Interestingly, we first reported that loss of DLG5 inhibited the interaction of Mst1 and Lats1 with Scribble, which was crucial for YAP activation and the transcription of TEA domain (TEAD) family members. In summary, loss of DLG5 expression promoted breast cancer malignancy by inactivating the Hippo signaling pathway and increasing nuclear YAP. Nature Publishing Group 2017-02-07 /pmc/articles/PMC5294562/ /pubmed/28169360 http://dx.doi.org/10.1038/srep42125 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Liu, Jie
Li, Juan
Li, Pingping
Wang, Yaochun
Liang, Zheyong
Jiang, Yina
Li, Jing
Feng, Chen
Wang, Ruiqi
Chen, He
Zhou, Can
Zhang, Jianmin
Yang, Jin
Liu, Peijun
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
title Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
title_full Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
title_fullStr Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
title_full_unstemmed Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
title_short Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
title_sort loss of dlg5 promotes breast cancer malignancy by inhibiting the hippo signaling pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294562/
https://www.ncbi.nlm.nih.gov/pubmed/28169360
http://dx.doi.org/10.1038/srep42125
work_keys_str_mv AT liujie lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT lijuan lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT lipingping lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT wangyaochun lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT liangzheyong lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT jiangyina lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT lijing lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT fengchen lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT wangruiqi lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT chenhe lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT zhoucan lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT zhangjianmin lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT yangjin lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway
AT liupeijun lossofdlg5promotesbreastcancermalignancybyinhibitingthehipposignalingpathway